Air pollution, a warm bedroom, and high levels of carbon dioxide and ambient noise may all adversely affect our ability to get a good night’s sleep, suggests a study from researchers with the Perelman School of Medicine at the University of Pennsylvania and the University of Louisville.
Results from a preclinical study from Penn Medicine, presented at the AACR Annual Meeting 2023, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.
Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances across the full spectrum of cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2023 from April 14-19 in Orlando, Florida.
When a youth baseball player in Mt. Airy steps into the batter’s box, the field will be clean and first aid kits will be stocked. When West Philadelphia residents seek assistance on coping with trauma, or GED assistance, additional help will be there. And when youths age out of Philadelphia’s foster care system, potentially losing eligibility for government services, they will be met with new opportunities for job training, professional development and more, supported by the Penn Medicine CAREs program.
Four distinguished researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will receive 2023 Scientific Achievement Awards from the American Association for Cancer Research (AACR), during the AACR Annual Meeting 2023.
Brain development follows a newly identified, non-uniform developmental sequence rendering youth to environmental impacts through adolescence.
Chronic kidney disease is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. A new risk model for cardiovascular disease, developed by Penn, was found to be more accurate than existing clinical models.
George Jabboure Netto, MD, an internationally recognized physician-scientist specializing in genitourinary pathology and molecular genetic pathology, has been named chair of the department of Pathology and Laboratory Medicine at Penn Medicine, effective Aug. 1, 2023.
The Penn Medicine Princeton Cancer Center received a $2.5 million grant from the Bristol Myers Squibb Foundation to help fund an innovative program to ensure holistic, patient-centered care for older adults with cancer.
Roughly one million people die of untreated kidney failure, worldwide, each year. Despite the major personal and economic burden, only a few new approaches have been deployed to treat or cure kidney disease over the last 40 years.
A new approach that delivers a “one-two punch” to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Even decades after delivering pre-term or with conditions like gestational diabetes or high blood pressure, those with complications in pregnancy or birth have a higher risk of death
Up to 50 percent of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Nature Communications, suggest there may be new opportunities to treat cancer with new or existing drugs.
Three faculty from the Perelman School of Medicine at the University of Pennsylvania have been named 2023 Hastings Center Fellows. Emily Largent, PhD, RN, Peter Reese, MD, PhD, and Dominic Sisti, PhD, are among 12 new Fellows joining an elected group of over 200.
A study published recently in JAMA Network Open, led by Mira Mamtani, MD, MSEd, an associate professor of Emergency Medicine, found vast differences in the feedback given and received by emergency medicine residents. Mamtani draws upon the findings of the study to offer guidance for providing better feedback.
The Pennsylvania Commission on Crime and Delinquency (PCCD) awarded over $5 million in grants to three community violence prevention and intervention programs across Penn Medicine. The Penn Medicine programs not only aim to reduce and prevent community violence, but also address the lasting impacts of violence on victims, such as treating their mental health, and helping them utilize social service agencies.
A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of Philadelphia (CHOP) created a center to study epilepsy and neurodevelopmental disorders.
The University of Pennsylvania’s Perelman School of Medicine (PSOM) today announced that it will no longer submit data for participation in the U.S. News and World Report (USNWR) annual “Best Medical Schools” rankings.
A new study reveals adults who suffered any head injury during a 30-year study period had two times the rate of mortality than those who did not have any head injury, and mortality rates among those with moderate or severe head injuries were nearly three times higher.
Electronic nudges delivered to health care clinicians based on a machine learning algorithm that predicts mortality risk quadrupled rates of conversations with patients about their end-of-life care preferences, according to the long-term results of a randomized clinical trial published by Penn Medicine investigators in JAMA Oncology today.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right